Back to Awarded Treatment Trials
Awarded Trial: 02T-269
Grant ID
02T-269
Illness
Schizophrenia Prodrome
Primary Drug/Intervention
Risperidone
Primary Dosage
0.5mg-1.0mg
Secondary Drug Intervention
Sertraline
Secondary Dosage
50mg-150mg
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Terminated
Investigator
Cornblatt
Sample Size
60
Duration of Study Period for Each Subject
16 weeks
Outcome Measurements
Scale of Prodromal Symptoms (SOPS), Children's Depression Inventory, Beck Depression Inventory, quality of life, global assessment of functioning, cognitive battery
Results
Terminated by the principal investigator, as a sufficient number of subjects could not be enrolled.
Publication
N/A
Link
N/A
PI Name
Barbara Cornblatt
Degree
PhD
Center
N/A
Institution
Zucker - Hillside Hospital
Address
A Division of Long Island Jewish Medical Center, 75-59 263rd Street
City or Town
Glen Oaks
State or Province
NY
Zip or Postal Code
11004
Country
USA
Email Address
cornblat@lij.edu